Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose

NCT04715230 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision based on slower than anticipated enrollment leading to fund exhaustion.

Conditions

Interventions

Sponsor

InterveXion Therapeutics, LLC

Collaborators